Front Immunol 8:1734 Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD, Hansen AMK, Reinecke M, Konrad D, Gassmann M, Reimann F, Halban PA, Gromada J, Drucker DJ, Gribble FM, Ehses JA, Donath MY (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
Assigning E11.40 to a Type 1 diabetic patient, or E10.40 to a Type 2 patient, is a coding error that payers may flag during claims review
The researchers found increased risk of several forms of alopecia among those taking GLP-1 medications
Keep reconstitution and handling guidance separate unless validated compatibility data is available
10.1182/blood-2002-11-3622
To address a detention, importers must act promptly